Minority patients underrepresented in Covid-19 trials despite greater willingness to participate, report finds
When Wanda McClain was working at Brigham and Women’s Hospital last March and April, she and other clinicians noticed something about the sick patients occupying beds.
“They were much more diverse than, you know, our traditional patients,” the former VP of community health and health equity said. “It showed very clearly the disproportionate impact that Covid is having on communities of color.”
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters